Join
Minerva Surgical Inc. logo

UTRS

NASDAQ

Minerva Surgical Inc.

SectorTechnologyIndustryComputer Software: Prepackaged SoftwareIPO2021
$1.52-0.02 (-1.62%)
News25/Ratings6

Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Latest news

25 items

UTRS FAQ

7 questions
  • What does Minerva Surgical Inc. do?
    Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld...
  • Where does UTRS stock trade?
    Minerva Surgical Inc. (UTRS) is listed on NASDAQ.
  • What sector and industry is UTRS in?
    Minerva Surgical Inc. operates in the Technology sector, Computer Software: Prepackaged Software industry.
  • When did Minerva Surgical Inc. go public?
    Minerva Surgical Inc. (UTRS) completed its IPO in 2021.
  • What are analysts saying about UTRS?
    Minerva Surgical Inc. has had 6 recent analyst actions on file. The most recent action was from Piper Sandler: Overweight with a $1200.00 price target on 2022-03-09. Recent price targets range from $1200.00 to $1700.00.
  • What companies are similar to UTRS?
    Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRWD (CrowdStrike Holdings Inc.), CRM (Salesforce Inc.). Compare UTRS side-by-side with any of them on Quantisnow.
  • How can I track UTRS on Quantisnow?
    Quantisnow aggregates Minerva Surgical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow UTRS to receive live email and push alerts on every new disclosure.